Загрузка...
A Pseudomonas aeruginosa-Derived Particulate Vaccine Protects against P. aeruginosa Infection
Despite numerous efforts to develop an effective vaccine against Pseudomonas aeruginosa, no vaccine has yet been approved for human use. This study investigates the utility of the P. aeruginosa inherently produced polyhydroxyalkanaote (PHA) inclusions and associated host–cell proteins (HCP) as a par...
Сохранить в:
| Опубликовано в: : | Vaccines (Basel) |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8309987/ https://ncbi.nlm.nih.gov/pubmed/34358220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9070803 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|